CD4 and Patent ductus arteriosus: Further, we found that, similar to CRC and PDA, VentX-regulated-TAMs (VentX-TAMs) re-program the immune landscape of NSCLC-TME from suppression to activation by modulating the differentiation of NSCLC-TAMs and CD4 T cells (Figures 3A–3D).